Nature 510, 298–302 (2014); doi:10.1038/nature13236

In the interests of transparency, we wish to amend the ‘Competing financial interests’ section of our Letter to read: “J.D.R. is the only author with a competing financial interest with respect to the current manuscript. He is involved in the founding of Raze Therapeutics.”